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UM NEUROSCIENTIST FINDS CLUE TO CNS REGENERATION 
MISSOULA—
A neuroscientist at The University of Montana-Missoula has discovered that a well- 
known enzyme could be an important link in improving recovery of the central nervous system 
after injury.
Diana Lurie, a UM assistant professor of pharmaceutical sciences, has found that SHP- 
1, an enzyme thought to play a role in regulating cell division, is present in large amounts in 
certain brain cells after injury. Lurie wants to know whether SHP-1 helps or hinders CNS 
regeneration.
“Neurons — the nerve cells in the brain or spinal cord — will regenerate a little bit,” 
Lurie said, “but when they reach the area of the lesion, the scar, they generally stop growing. 
And it’s not the scar that makes a physical barrier; it’s something about the chemical 
composition of the scar that prevents regeneration.”
Lurie said that if one were to take those neurons and let them grow in the peripheral 
nervous system, they would grow for much longer distances. It’s the environment in the CNS 
that prevents their regeneration, she said. Lurie studies the cells that make up that 
environment.
“Those cells are called glial cells,” she said. “Neurons are surrounded by glial cells. 




But scientists know that some glial cells -- astrocytes -- divide after injury, Lurie said, 
and the increase in cells is part of what forms the scar. But not all astrocytes divide. If they 
did, Lurie said, scars would be huge and tumor-like after injury.
What Lurie has found is a group of astrocytes in the brain that contain SHP-1 after 
injury. Normally the brain has low levels of the enzyme, she said.
“In a group of cells that normally don’t have a lot of this enzyme, suddenly they have a 
lot, and you can see it after injury,” she said. “And it looks like the cells that don’t divide 
have SHP-1 in them. So perhaps SHP-1 is made by the cells to prevent them from dividing.” 
The question for Lurie is whether these cells that don’t divide release chemicals into the 
environment that help neurons to grow, or whether these cells inhibit regeneration.
Lurie said researchers have recently identified chemicals some astrocytes produce that 
may be good for regeneration, but their studies haven’t located which astrocytes are producing 
the chemicals. Lurie’s discovery of a group of astrocytes that produce SHP-1 advances that 
research.
“We now have a marker for another subset of astrocytes that seem to be doing 
something a little bit different besides dividing after injury,” she said. “My lab is trying to 
figure out what they are doing. If we could genetically put SHP-1 into all the glial cells in the 
brain, would the brain recover well after injury or not?”
Lurie does much of this research on young chickens. To stimulate changes in their 
brains similar to an injury, she removes the cochlea -- the organ in the inner ear that translates 
sound waves into electrical signals that convey information to the brain. Removing the cochlea 
stops the electrical signals, which then causes changes to that area of the brain where the
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information first enters: Some of the neurons die, and some of the surrounding astrocytes start 
to divide. Those containing SHP-1 don’t divide.
"It seems to be a general feature of nervous system injury, so I think we’re talking 
about a very basic mechanism here in terms of the regulation of what happens in the brain after 
injuries,” Lurie said.
Historically in this field of research, Lurie said, a scientist would injure, for example, a 
rat spinal cord and then “throw all kinds of different substances in to see if they would help 
regeneration." Nothing really helped much, she said, so researchers decided it was time to 
step back and look at basic mechanisms of what happens after injury and use that information 
to design a therapy.
“Ultimately the goal of any biomedical research is to develop a therapy,” Lurie said. 
“For me that therapy would be to improve or even get some significant functional central 
nervous system recovery after injury.”
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